[French Expert advice on the management of valproate in childbearing and pregnant women with bipolar disorder].

[1]  M. Leboyer,et al.  Evolution and characteristics of the use of valproate in women of childbearing age with bipolar disorder: Results from the FACE-BD cohort. , 2020, Journal of affective disorders.

[2]  E. Vieta,et al.  Expert advice on the management of valproate in women with bipolar disorder at childbearing age , 2019, European Neuropsychopharmacology.

[3]  M. Bauer,et al.  Predictors and outcomes of suicidal ideation during peripartum period. , 2019, Journal of affective disorders.

[4]  P. Llorca,et al.  Pharmacotherapy for the peripartum management of bipolar disorder , 2019, Expert opinion on pharmacotherapy.

[5]  T. Tomson,et al.  Teratogenicity of antiepileptic drugs , 2019, Current opinion in neurology.

[6]  F. Gressier,et al.  Impact of a prenatal episode and diagnosis in women with serious mental illnesses on neonatal complications (prematurity, low birth weight, and hospitalization in neonatal intensive care units) , 2018, Archives of Women's Mental Health.

[7]  S. Kochen,et al.  Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry , 2018, The Lancet Neurology.

[8]  T. Schulze,et al.  Bipolar Disorders , 2019, Springer Netherlands.

[9]  S. Vigod,et al.  Perinatal suicide in Ontario, Canada: a 15-year population-based study , 2017, Canadian Medical Association Journal.

[10]  A. Tricco,et al.  Comparative safety of anti-epileptic drugs during pregnancy: a systematic review and network meta-analysis of congenital malformations and prenatal outcomes , 2017, BMC Medicine.

[11]  J. Clayton-Smith,et al.  Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. , 2016, The Cochrane database of systematic reviews.

[12]  T. Tomson,et al.  Valproic acid after five decades of use in epilepsy: time to reconsider the indications of a time-honoured drug , 2016, The Lancet Neurology.

[13]  S. Kushner,et al.  Risk of Postpartum Relapse in Bipolar Disorder and Postpartum Psychosis: A Systematic Review and Meta-Analysis. , 2015, The American journal of psychiatry.

[14]  Michael Berk,et al.  Bipolar disorder , 2006, The Lancet.

[15]  W. Bobo,et al.  Treatment of bipolar disorders during pregnancy: maternal and fetal safety and challenges , 2014, Drug, healthcare and patient safety.

[16]  E. Vieta,et al.  Patterns of pharmacological maintenance treatment in a community mental health services bipolar disorder cohort study (SIN-DEPRES). , 2013, The international journal of neuropsychopharmacology.

[17]  H. Möller,et al.  The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2012 on the long-term treatment of bipolar disorder , 2013, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

[18]  K. Meador,et al.  Fetal antiepileptic drug exposure and cognitive outcomes at age 6 years (NEAD study): a prospective observational study , 2013, The Lancet Neurology.

[19]  B. Wlodarczyk,et al.  Antiepileptic drugs and pregnancy outcomes , 2012, American journal of medical genetics. Part A.

[20]  S. Kushner,et al.  Prevention of postpartum psychosis and mania in women at high risk. , 2012, The American journal of psychiatry.

[21]  K. Meador,et al.  Fetal antiepileptic drug exposure: Motor, adaptive, and emotional/behavioral functioning at age 3years , 2011, Epilepsy & Behavior.

[22]  S. Vigod,et al.  Diagnosis, Pathophysiology, and Management of Mood Disorders in Pregnant and Postpartum Women , 2011, Obstetrics and gynecology.

[23]  E. Vieta,et al.  Group psychoeducation for stabilised bipolar disorders: 5-year outcome of a randomised clinical trial , 2009, British Journal of Psychiatry.

[24]  R. Baldessarini,et al.  Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation. , 2007, The American journal of psychiatry.

[25]  R. Fieve,et al.  Continuation versus discontinuation of lithium in recurrent bipolar illness: a naturalistic study. , 2007, Bipolar disorders.

[26]  R. Baldessarini,et al.  Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. , 1999, Bipolar disorders.